QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 senti-biosciences-snti-stock-is-up-over-100-whats-happening

Senti Biosciences shares are trading higher by 102.6% during Monday's session. The company was awarded $8 million from the ...

 senti-biosciences-q1-eps-026-up-from-042-yoy

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.26) per share. This is a 38.1 percent increase over losses of ...

 senti-biosciences-q4-2023-gaap-eps-042-misses-028-estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $...

 senti-biosciences--said-reducing-its-workforce-by-37-as-part-of-prioritizing-its-investment-in-lead-clinical-program

Senti Biosciences, Inc. (NASDAQ:SNTI) (“Senti Bio” or the “Company”), a clinical stage biotechnology company developing next-ge...

 why-is-blood-cancer-focused-senti-biosciences-stock-trading-higher-today

Senti Biosciences Inc (NASDAQ: SNTI) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, a...